Inovio Pharmaceuticals, Inc. (INO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Inovio Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.60x | -0.46x | -1.00x | -1.33x | -42.32x | -105.53x |
| P/B Ratio | 33.86x | 0.73x | 1.16x | 1.67x | 32.16x | 38.08x |
| P/S Ratio | 12485.24x | 228.26x | 163.10x | 36.27x | 7241.33x | 2369.48x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -132871.3% | -51616.9% | -17300.3% | -2607.4% | -16972.3% | -1674.2% |
| Net Margin | -130000.0% | -49254.3% | -16239.9% | -2726.7% | -17109.9% | -2245.4% |
| EBITDA Margin | -125425.9% | -47735.2% | -15671.8% | -2639.8% | -16709.7% | -2018.0% |
| Liquidity | ||||||
| Current Ratio | 1.40x | 2.77x | 3.60x | 3.25x | 6.82x | 11.30x |
| Quick Ratio | 1.40x | 2.77x | 3.60x | 3.25x | 6.82x | 11.30x |
| Leverage | ||||||
| Debt/Equity | 0.39x | 0.17x | 0.26x | 0.14x | 0.08x | 0.08x |
YoY = year-over-year change. Source: FMP..